Atopic Keratoconjunctivitis Akc clinical trials

Explore recruiting atopic keratoconjunctivitis akc clinical trials.

Recruiting atopic keratoconjunctivitis akc studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Atopic Keratoconjunctivitis Akc trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A 4-Week, Phase II, Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel Group Study With 2 Weeks of Follow-Up to Evaluate Safety and Efficacy of Two Different Dosages of Isocyclosporin A Eye Drop Solution Versus Vehicle in Adult Patients with Atopic Keratoconjunctivitis (AKC).

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Study to Demonstrate Efficacy and Safety of DFL24498 Eye Drop Solution in Adult Participants with Atopic Keratoconjunctivitis (AKC)

Spain, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Atopic Keratoconjunctivitis Akc trials by city

Atopic Keratoconjunctivitis Akc in Toronto Atopic Keratoconjunctivitis Akc in Vancouver Atopic Keratoconjunctivitis Akc in Montreal Atopic Keratoconjunctivitis Akc in Calgary Atopic Keratoconjunctivitis Akc in Edmonton Atopic Keratoconjunctivitis Akc in Ottawa Atopic Keratoconjunctivitis Akc in Winnipeg Atopic Keratoconjunctivitis Akc in Quebec City Atopic Keratoconjunctivitis Akc in Hamilton Atopic Keratoconjunctivitis Akc in Kitchener Atopic Keratoconjunctivitis Akc in London Atopic Keratoconjunctivitis Akc in Halifax Atopic Keratoconjunctivitis Akc in New York Atopic Keratoconjunctivitis Akc in Los Angeles Atopic Keratoconjunctivitis Akc in Chicago Atopic Keratoconjunctivitis Akc in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease